Related Experiment Video
Updated: Jun 13, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
VEXAS Syndrome with an Improvement of Chest Shadows Without Immunosuppressive Therapy: A Case Report
Kazuki Tanaka1, Akira Kawamura1, Ryo Suzuki1
1Department of Respiratory Internal Medicine, Fujieda Municipal General Hospital, Japan.
Abstract:
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is an acquired autoinflammatory disease caused by UBA1 variants. We report an 86-year-old man with high C-reactive protein levels, bicytopenia, and bilateral chest shadows. Bronchoalveolar lavage revealed an elevated lymphocyte count. Bone marrow vacuoles and a UBA1 (c.122T>C p.Met41Thr) variant with a high variant allele frequency (VAF) confirmed VEXAS. Although he refused treatment, chest shadows improved without immunosuppressive therapy and remained stable for two months, despite the persistence of systemic inflammatory symptoms and elevated C-reactive protein levels. This case highlights the clinical heterogeneity of VEXAS syndrome, demonstrating that pulmonary involvement can be self-limiting despite high VAF and atypical lavage findings, suggesting careful consideration of the treatment timing.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

